{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:26:01Z","timestamp":1790691961942,"version":"4.1.0"},"reference-count":56,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OTT"],"DOI":"10.2147\/ott.s267001","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T08:10:21Z","timestamp":1629447021000},"page":"4509-4521","source":"Crossref","is-referenced-by-count":19,"title":["Clinical Utility of Fedratinib in Myelofibrosis"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Julian A","family":"Waksal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4719-7192","authenticated-orcid":true,"given":"Douglas","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/ajh.25230","volume":"93","author":"Tefferi","year":"2018","journal-title":"Am J Hematol"},{"key":"ref2","first-page":"121","volume":"16","author":"O\u2019Sullivan","year":"2018","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-579136","volume":"124","author":"Tefferi","year":"2014","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41408-019-0175-y","volume":"9","author":"Vallapureddy","year":"2019","journal-title":"Blood Cancer J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/leu.2014.3","volume":"28","author":"Tefferi","year":"2014","journal-title":"Leukemia"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/leu.2008.275","volume":"23","author":"da Costa Reis Monte-m\u00f3r","year":"2009","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"18177","DOI":"10.1074\/jbc.M600064200","volume":"281","author":"Walz","year":"2006","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMoa1110556","volume":"366","author":"Harrison","year":"2012","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1110557","volume":"366","author":"Verstovsek","year":"2012","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13045-017-0527-7","volume":"10","author":"Verstovsek","year":"2017","journal-title":"J Hematol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/13696998.2020.1741381","volume":"23","author":"Mascarenhas","year":"2020","journal-title":"J Med Econ"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/cncr.32664","volume":"126","author":"Palandri","year":"2020","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1182\/blood-2017-05-783225","volume":"130","author":"Newberry","year":"2017","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/jamaoncol.2015.1590","volume":"1","author":"Pardanani","year":"2015","journal-title":"JAMA oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1016\/S2352-3026(17)30088-1","volume":"4","author":"Harrison","year":"2017","journal-title":"Lancet Haematol"},{"key":"ref16","unstructured":"Center for drug evaluation and research multi-discipline review, Application Number: 212327Orig1s000; 2019. Available from:\u00a0https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/212327Orig1s000MultidisciplineR.pdf. Accessed August 16, 2021."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3324\/haematol.2016.143677","volume":"101","author":"Al-Ali","year":"2016","journal-title":"Haematologica"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1182\/blood-2016-11-731604d","volume":"129","author":"Francisco Cervantes","year":"2017","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1182\/blood-2016-11-731604","volume":"129","author":"Cervantes","year":"2017","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"CD010298","DOI":"10.1002\/14651858.CD010298.pub2","author":"Marti-Carvajal","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrc2210","volume":"7","author":"Levine","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref22","unstructured":"Ruxolitinib [package insert]. Wilmington, DE: Incyte Corporation; 2011."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13045-018-0585-5","volume":"11","author":"Kvasnicka","year":"2018","journal-title":"J Hematol Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41467-019-13892-x","volume":"11","author":"Mylonas","year":"2020","journal-title":"Nat Commun"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.4065\/mcp.2011.0518","volume":"86","author":"Tefferi","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1371\/journal.pone.0000018","volume":"1","author":"Zaleskas","year":"2006","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ccr.2008.02.009","volume":"13","author":"Wernig","year":"2008","journal-title":"Cancer Cell"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/sj.onc.1205332","volume":"21","author":"Kiyoi","year":"2002","journal-title":"Oncogene."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMoa1614359","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1056\/NEJMoa1902688","volume":"381","author":"Perl","year":"2019","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nchembio.1471","volume":"10","author":"Ciceri","year":"2014","journal-title":"Nat Chem Biol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ccell.2017.12.007","volume":"33","author":"Jiang","year":"2018","journal-title":"Cancer Cell"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ccell.2018.03.024","volume":"33","author":"Kleppe","year":"2018","journal-title":"Cancer Cell"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1182\/blood-2012-01-402396","volume":"120","author":"Mullally","year":"2012","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1111\/jcmm.12608","volume":"19","author":"Debeurme","year":"2015","journal-title":"J Cell Mol Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1200\/JCO.2010.32.8021","volume":"29","author":"Pardanani","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/cpdd.161","volume":"4","author":"Zhang","year":"2015","journal-title":"Clin Pharmacol Drug Dev"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1038\/bcj.2015.63","volume":"5","author":"Pardanani","year":"2015","journal-title":"Blood Cancer J"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ajh.25777","volume":"95","author":"Harrison","year":"2020","journal-title":"Am J Hematol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/jcph.218","volume":"54","author":"Zhang","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1124\/dmd.114.058883","volume":"42","author":"Zhang","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.canep.2015.01.014","volume":"39","author":"Wu","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41408-018-0167-3","volume":"9","author":"Gangat","year":"2019","journal-title":"Blood Cancer J"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.4197.4197Sd","author":"Claire","year":"2017","journal-title":"Blood"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s11604-020-00989-3","volume":"38","author":"Ota","year":"2020","journal-title":"Jpn J Radiol"},{"key":"ref47","unstructured":"Fedratinib [package insert]. Summit (NJ): Celgene Corporation; 2019."},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129288Sd","author":"Harrison","year":"2019","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"16609","DOI":"10.1038\/s41598-019-53056-x","volume":"9","author":"Sapre","year":"2019","journal-title":"Sci Rep"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"D T, L C, SR B, S R, J M. The effect of fedratinib, a selective inhibitor of Janus Kinase 2 (JAK2), on weight and metabolic parameters in patients with intermediate (INT)- or high-risk Myelofibrosis (MF). Blood. 2020;136:16\u201317.","DOI":"10.1182\/blood-2020-137293"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Harrison C, Kiladjian J, Verstovsek S, et al. Overall and progression-free survival in patients treated with fedratinib as first-line Myelofibrosis (MF) therapy and after prior Ruxolitinib (RUX): results from the jakarta and jakarta2 trials; 2021.","DOI":"10.1016\/S2152-2650(21)01822-X"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129288","author":"Harrison","year":"2019","journal-title":"Blood"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ccr.2010.05.015","volume":"17","author":"Mullally","year":"2010","journal-title":"Cancer Cell"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1016\/j.clml.2018.06.025","volume":"18","author":"Gerds","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1002\/cncr.33541","volume":"127","author":"Palandri","year":"2021","journal-title":"Cancer"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3390\/cells10051034","volume":"10","author":"Tremblay","year":"2021","journal-title":"Cells"}],"container-title":["OncoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=72825","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=72825","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T14:00:58Z","timestamp":1673100058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/clinical-utility-of-fedratinib-in-myelofibrosis-peer-reviewed-fulltext-article-OTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":56,"URL":"https:\/\/doi.org\/10.2147\/ott.s267001","relation":{},"ISSN":["1178-6930"],"issn-type":[{"value":"1178-6930","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}